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Abstract
Background: Acute inferior ST-segment elevation myocardial infarction (STEMI) is as-
sociated with increased in-hospital morbidity and mortality particularly among patients with 
coexisting right ventricular (RV) involvement. High neutrophil to lymphocyte ratio (NLR) is 
an independent predictor of major adverse cardiac events and mortality in patients with myo-
cardial infarction. This study evaluated the relationship between the NLR and RV dysfunc-
tion (RVD) in patients with inferior STEMI who underwent primary percutaneous coronary 
intervention (PCI).
Methods: A total of 213 subjects with inferior STEMI were divided into two groups accord-
ing to the presence of RVD. The groups were compared according to NLR and receiver operating 
characteristic (ROC) analysis was performed to access the predictability of NLR on having RVD.
Results: The NLR was significantly higher in the group with RVD compared to that without 
RVD (p < 0.001). In ROC analysis, NLR > 3.5 predicted RVD with sensitivity of 83% and 
specificity of 55%. In a multivariate regression analysis, NLR remained an independent pre-
dictor of RVD (OR 1.55, 95% CI 1.285–1.750, p < 0.001).
Conclusions: NLR was an independent predictor of RVD in patients with inferior STEMI 
undergoing primary PCI. (Cardiol J 2016; 23, 1: 100–106)
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Introduction
Autopsy findings showed that right ventricu-
lar (RV) involvement is observed in up to 50% of 
patients with inferior ST-segment elevation myo-
cardial infarction (STEMI) [1, 2]. Acute inferior 
STEMI is associated with increased in-hospital 
morbidity and mortality particularly among patients 
with coexisting RV involvement [3, 4]. However, 
long-term prognosis is generally good for those 
who survive the event.
Inflammation plays an important role in the 
pathogenesis and progression of the atherosclero-
sis [5, 6]. The neutrophil to lymphocyte ratio (NLR) 
shows balance between neutrophil and lymphocyte 
levels and can be used as an indicator of systemic 
inflammation. High NLR is an independent predic-
tor of major adverse cardiac events and mortality in 
patients with acute myocardial infarction (MI) [7]. 
Although predictive value of NLR in patients with 
STEMI is well known, the relationship between 
NLR and the inferior STEMI with RV dysfunction 
(RVD) has not been evaluated before. Therefore, 
the aim of the present study was to evaluate the 
association between the NLR and RV function 
among patients with inferior STEMI undergoing 
primary percutaneous coronary intervention (PCI).
Methods
Patient population
This prospective study was conducted be-
tween January 2012 and January 2015. A total of 
213 subjects with inferior STEMI presented within 
12 h from the symptom onset were included in 
the study. All patients were treated with primary 
PCI. Inferior STEMI was defined as ST-segment 
elevation > 1 mm in any two consecutive inferior 
leads. Right precordial electrocardiograms (V3R 
through V6R) were recorded immediately after 
admission to the emergency room. ST-segment 
elevation was measured 0.08 s after the J point 
in V4R. Three consecutive QRS complexes were 
measured with the PQ level used as the isoelectric 
line. All analyses were performed by a cardiolo-
gist blinded to the clinical data of the patient. By 
the help of electrocardiogram of each patient, the 
presence of ST-segment elevation ≥ 1 mm in lead 
V4R searched accordingly.
Exclusion criteria were treatment with fibrino-
lytics in the previous 24 h, presence of active infec-
tion, chronic pulmonary disease, pulmonary hyper-
tension, malignancy, end-stage liver disease, renal 
failure and past history of a systemic inflammatory 
process. Informed consent of each subject and ap-
proval of the Local Ethics Committee were obtained.
Angiographic variables were multivessel coro-
nary artery disease, thrombolysis in myocardial 
infarction (TIMI) flow in main right coronary artery 
before primary PCI. The TIMI flow grades were as-
sessed as previously described [8]. The site of oc-
clusion of the right coronary artery was defined as 
proximal or distal based on the origin of the major 
(> 1 mm in diameter) RV branch. The purpose of 
the primary PCI procedure was to obtain a residual 
stenosis of < 20% in the infarct-related artery by 
visual evaluation. A successful angiographic result 
was defined as residual stenosis < 20% associated 
with TIMI grade 2–3 flow. All patients received dual 
antiplatelet therapy with aspirin and clopidogrel 
(600 mg) or ticagrelor (180 mg) loading dose. Pre-
procedural anticoagulation consisted of intravenous 
unfractionated heparin (70 IU/kg) in all cases. PCI 
with stent implantation was performed according 
to current guidelines [9].
Patients underwent standard 2-dimensional 
echocardiography with a digital ultrasonic device 
system (iE33; Philips, Netherlands) immediately 
after PCI. RVD was defined according to the recom-
mendations of American Society of Echocardiography 
[10]. Patients were divided into two groups: patients 
with normal RV function (TAPSE > 17) (group 1), and 
patients with RVD (TAPSE £ 17) (group 2).
In all patients, blood samples were collected from 
antecubital vein at emergency room for laboratory 
analysis. Complete blood count (CBC) parameters 
were measured by an ABX Pentra DX 120 hemato-
logy analyzer immediately after sampling. Biochemi-
cal parameters were measured by the Roche Cobas 
Integra 800 (Roche diagnostic limited, Switzerland) 
and troponin-I was measured by an AQT 90 Flex im-
munoassay analyzer (Radio meter, Denmark).
Statistical analysis
Categorical variables were compared with 
c2 or Fisher’s exact test when appropriate. Continu-
ous variables were presented as mean + standard 
deviation, whereas categorical variables as count 
and percentages. The Kolmogorov-Smirnov test 
was used to evaluate whether the distribution 
of continuous variables was normal. Continuous 
variables were compared with Student’s t test or 
Mann-Whitney U test as appropriate. Receiver 
operating characteristic (ROC) curve was used to 
assign the sensitivity and specificity of NLR and 
the optimal cut-off value for predicting RVD in pa-
tients with inferior STEMI. Association of different 
variables with RVD was calculated in univariate 
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analysis. Backward stepwise logistic regression 
analysis was used to assess independent predic-
tors of RVD. A p value < 0.05 was considered 
statistically significant. All statistical studies were 
carried out using Statistical Package for Social 
Sciences software (SPSS 18.0 for Windows, SPSS 
Inc., Chicago, Illinois).
Results
Baseline characteristics are presented in 
Table 1. There were no statistically significant 
differences in respect to demographic, baseline 
clinical values, coronary risk factors and in-hospital 
therapy between the groups. Peak troponin I was 
Table 1. Baseline characteristics, electrocardiogaphic characteristics and in-hospital therapy.
Variable Right ventricular dysfunction P
Absent (n = 120) Present (n = 93)
Age [years] 56.5 ± 10.2 55.8 ± 10.9 0.62
Male 94 (78.3%) 76 (81.7%) 0.54
Hypertension 66 (55%) 53 (57%) 0.77
Diabetes mellitus 29 (24.2%) 23 (24.7%) 0.92
Smoke 67 (56%) 57 (61%) 0.33
Body mass index [kg/m2] 25.2 ± 3.1 25.7 ± 3.0 0.20
Family history of CAD 25 (20.8%) 20 (21.5%) 0.90
Previous MI 24 (20%) 17 (18.3%) 0.75
Previous PCI 11 (9.2%) 10 (10.8%) 0.70
Previous CABG 3 (2.5%) 4 (4.3%) 0.50
GFR [mL/min/1.73 m2] 83.1 ± 4.6 82.4 ± 4.4 0.28
Heart rate [bpm] 72.3 ± 15.6 70.3 ± 18.9 0.60
Glucose on admission 161 ± 76.7 170 ± 79.4 0.15
Peak troponin I [ng/dL] 6.1 ± 2.3 6.7 ± 2.7 0.04
Triglyceride [ng/dL] 159.0 ± 83.1 167.3 ± 78.5 0.30
Total cholesterol [mg/dL] 178 ± 43.0 185.6 ± 42.9 0.25
Low-density lipoprotein [mg/dL] 119.3 ± 33.4 124.6 ± 32.1 0.18
High-density lipoprotein [mg/dL] 35.8 ± 9.2 36.0 ± 9.3 0.80
Hemoglobin [g/L] 14.0 ± 2.3 14.7 ± 2.9 0.60
Platelet [/mm3] 260.5 ± 75.0 264.0 ± 60.5 0.20
White blood cell count [103/µL] 10.2 ± 3.3 12.8 ± 3.4 0.007
Neutrophils [103/µL] 7.8 ± 3.2 10.7 ± 3.2 0.003
Lymphocytes [103/µL] 2.4 ± 0.9 2.0 ± 0.6 0.02
Neutrophil/lymphocyte ratio 3.9 ± 2.3 6.0 ± 2.8 < 0.001
Time from symptoms onset to PCI [h] 6.0 ± 1.5 6.5 ± 1.2 0.04
Door to balloon time [min] 65 ± 12.5 65.3 ± 13.7 0.40
V4R ST-elevation 17 (14.2%) 76 (81.7%) < 0.001
In-hospital therapy:
Aspirin 115 (96%) 90 (97%) 0.72
Beta-blocker 72 (60%) 56 (60%) 0.97
ACEI/AT-1 antagonist 71 (60%) 52 (56%) 0.63
Clopidogrel 109 (90.8%) 82 (88.2%) 0.53
Ticagrelor 11 (9.2%) 11 (11.8%) 0.52
Statin 115 (95.8%) 90 (96.8%) 0.72
Glycoprotein IIb/IIIa inhibitor 17 (14.1%) 15 (16.2%) 0.48
Data are expressed as mean ± standard deviation for normally distributed data or count (percentage) for categorical variables; CAD — coronary 
artery disease; MI — myocardial infarction; PCI — percutaneous coronary intervention; CABG — coronary artery bypass grafting;  
GFR — glomerular filtration rate; ACEI — angiotensin converting enzyme inhibitor
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significantly higher in patients with RVD. Average 
white blood cell count, neutrophils count and NLR 
were significantly higher while lymphocytes count 
were significantly lower in patients with RVD. 
Time from symptoms onset to PCI was significantly 
higher in patients with RVD. We performed further 
analyses and clustered time durations as follows: 
< 3 h, 3–6 h and > 6 h. Fifteen percent of the pa-
tients with RVD applied within first 3 h, 65% within 
3–6 h and 20% within 6–12 h of symptom onset 
while 60% of the patients without RVD applied 
within first 3 h, 25% within 3–6 h and 15% within 
6–12 h of symptom onset. There was a significant 
difference between the groups in respect to fre-
quency of these time durations. A larger proportion 
of the patients with ST-elevation in lead V4R was 
observed in patients with RVD.
Table 2 summarized angiographic results of 
the patients. A larger proportion of the patients 
with multivessel coronary disease was observed 
in patients without RVD. Coronary lesion location 
was significantly different between the two groups. 
A large proportion of patients with proximal lesion 
was observed in patients with RVD. There was no 
significant difference in TIMI flow before and after 
PCI between the two groups.
Echocardiographic findings are presented in 
Table 3. Mean tricuspid annular plane systolic 
excursion was significantly lower in patients with 
RVD. Consistently, RV fractional area changes were 
significantly lower in patients with RVD.
ROC curve of NLR for predicting RVD is shown 
in Figure 1. NLR of > 3.5 was found to predict RVD 
with sensitivity of 83% and specificity of 55%.
Some variables associated with RVD were 
significantly different between the two groups; 
and NLR was found to be an independent predic-
tor of RVD in the multivariable logistic regression 
analysis (odds ratio 1.55, 95% confidence interval 
1.285–1.750, p < 0.001; Table 4).
Discussion
Several factors involve impairment of perfu-
sion at tissue level after STEMI. These are white 
blood cell and platelet accumulation in capillar-
ies, inflammation-driven complex neutrophil and 
platelet interactions, reactive oxygen radicals, 
distal thrombus embolization, and endothelial 
dysfunction due to ischemia and reperfusion injury. 
Inflammation has a substantial contribution to this 
process. It has also a negative effect on myocardial 
function. Response of white blood cells to different 
inflammatory triggers leads to secretion of proin-
flammatory cytokines such as tumor necrosis fac-
tor-alpha, interleukin-6, and C-reactive protein. By 
the effects of these cytokines, contractile function 
of myocardium may decrease [11, 12]. Active neu-
trophils also secrete several proteolytic enzymes 
such as myeloperoxidase, acid phosphatase, and 
elastase which help destroying tissue structure, 
and neutrophil-driven microvascular obstruction 
Table 2. Angiographic characteristics.
Variable Right ventricular dysfunction P
Absent (n = 120) Present (n = 93)
Number of diseased coronary arteries: 0.04
1 54 (45%) 55 (60%)
> 1 66 (55%) 38 (41%)
Coronary lesion location at RCA: < 0.001
Proximal 32 (27%) 74 (80%)
Distal 88 (73%) 19 (20%)
TIMI flow before PCI in main RCA: 0.43
TIMI 0 97 (80.8%) 79 (84.9%)
TIMI 1 23 (19.2%) 14 (15.15)
TIMI flow after PCI in main RCA: 0.27
Unsuccessful 12 (10%) 14 (15%)
Successful 108 (90%) 79 (85%)
RCA — right coronary artery; PCI — percutaneous coronary intervention; TIMI — thrombolysis in myocardial infarction
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can worsen ischemia and lead infarct expansion, 
as well [13–17].
Several investigators reported that increased 
number of circulating neutrophils was indepen-
dently related to risk of heart failure and mortality 
Table 3. Echocardiographic characteristics.
Variable Right ventricular dysfunction P
Absent (n = 120) Present (n = 93)
Left ventricular end-systolic volume [mL] 55.5 ± 8.8 56.7 ± 10.4 0.35
Left ventricular end-diastolic volume [mL] 96.2 ± 11.2 97.5 ± 11.3 0.75
Left ventricular ejection fraction [%] 44.9 ± 2.6 44.2 ± 3.5 0.07
E/A ratio 1.1 ± 0.2 1.0 ± 0.2 0.23
E/e’ ratio 9.8 ± 3.3 9.8 ± 2.6 0.65
Moderate or severe mitral regurgitation 12 (9.5%) 10 (11.5%) 0.65
Moderate or severe tricuspid regurgitation 12 (9.5%) 15 (17.2%) 0.13
Right ventricular end-systolic volume [mL] 23.3 ± 5.0 26.2 ± 6.6 0.005
Right ventricular end-diastolic volume [mL] 40.2 ± 6.8 43.6 ± 7.5 0.001
Right ventricular end-systolic area [cm2] 12.0 ± 1.6 13.2 ± 2.2 0.003
Right ventricular end-diastolic area [cm2] 21 ± 2.8 19.2 ± 2.4 0.03
Right ventricular fractional area change [%] 38.8 ± 3.9 32.5 ± 5.5 < 0.001
Tricuspid annular plane systolic excursion [mm] 18.9 ± 1.2 12.8 ± 1.9 < 0.001
Inferior vena cava diameter [mm] 15.6 ± 1.7 18.7 ± 2.5 0.001
Inferior vena cava collapse with inspiration [%] 40.8 ± 17 32.8 ± 17 0.004
Figure 1. Characteristic operating curve (ROC) of neu-
trophil to lymphocyte ratio (NLR) for predicting right 
ventricular dysfunction.
in long-term following MI [18, 19]. In the other way, 
lymphocytopenia is a common finding secondary to 
increased corticosteroid levels induced by stress 
of coronary event [20]. Lymphocytopenia can 
also be found in non-cardiac patients with severe 
inflammation secondary to lymphocyte apoptosis 
[21]. Studies reported that lymphocytopenia was 
independently associated with mechanical compli-
cations and mortality in patients with acute STEMI 
[22, 23]. The combination of these two variables 
which is the ratio of neutrophils over lymphocytes 
reflects the balance between the neutrophil and 
lymphocyte levels is the basis for this study [24]. 
In the present study, it was found as a main finding 
that RVD was significantly associated with neutro-
phil and lymphocyte count, and the NLR.
The NLR has been evaluated in coronary artery 
disease and acute coronary syndromes [25–27]. 
Kaya et al. [28] evaluated the role of the NLR in 
patients with STEMI undergoing PCI and found 
that NLR is an independent predictor of both in-
hospital and long-term adverse outcomes. Arbel et 
al. [29] showed that STEMI patients with high NLR 
had lower ejection fraction and more complications 
during their index hospitalization. Also, Akpek et al. 
[7] showed that NLR is an independently associated 
with the development of no-reflow phenomenon.
Another main finding, made by the authors is 
that time duration from symptom onset to PCI has 
an independent predictor of RVD. It meant that the 
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patient applying earlier got more benefit from PCI 
which is in consistence with the literature [30] 
since the patients with RVD had more prolonged 
time duration compared to patients without RVD.
Neutropil to lymphocyte ratio is an universally 
available hematological marker which can be easily 
calculated. The results of the present study suggest 
that this diagnostic test might be used in addition 
to other tests to predict RVD in patients with acute 
inferior STEMI.
Limitations of the study
The sample size was relatively small. Other 
inflammatory markers such as high sensitivity- 
-C-reactive protein, myeloperoxidase or fibrinogen 
were not included. Evaluation of RV strain which 
might yield additional data on RV function in STEMI 
was not performed. Finally, some recovery in RV 
function might have occurred before echocardio-
graphic examination was performed. However, this 
does not imply that the results might be erroneous, 
rather the results are still statistically significant 
despite some neutralizing effects of normal RV func-
tion on the predictor power of the NLR.
Conclusions
Neutrophil to lymphocyte ratio was an inde-
pendent predictor of RVD in patients with inferior 
STEMI undergoing primary PCI.
Conflict of interest: None declared
References
1. Andersen HR, Falk E, Nielsen D. Right ventricular infarction: 
Frequency, size and topography in coronary heart disease: 
A prospective study comprising 107 consecutive autopsies from 
a coronary care unit. J Am Coll Cardiol, 1987; 10: 1223–1232.
2. Goldstein JA. Pathophysiology and management of right heart 
ischemia. J Am Coll Cardiol, 2002; 40: 841–853.
3. Zehender M, Kasper W, Kauder E et al. Right ventricular infarc-
tion as an independent predictor of prognosis after acute inferior 
myocardial infarction. N Engl J Med, 1993; 328: 981–988.
4. Mehta SR, Eikelboom JW, Natarajan MK et al. Impact of right 
ventricular involvement on mortality and morbidity in patients 
with inferior myocardial infarction. J Am Coll Cardiol, 2001; 37: 
37–43.
5. Kaya MG, Uyarel H, Akpek M et al. Prognostic value of uric 
acid in patients with ST-elevated myocardial infarction under-
going primary coronary intervention. Am J Cardiol, 2012; 109: 
486–491.
6. Akpek M, Kaya MG, Uyarel H et al. The association of serum 
uric acid levels on coronary flow in patients with STEMI under-
going primary PCI. Atherosclerosis, 2011; 219: 334–341.
7. Akpek M, Kaya MG, Lam YY et al. Relation of neutrophil/lym-
phocyte ratio to coronary flow to in-hospital major adverse car-
diac events in patients with ST-elevated myocardial infarction 
undergoing primary coronary intervention. Am J Cardiol, 2012; 
110: 621–627.
8. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I 
findings. TIMI Study Group. N Engl J Med, 1985; 312: 932–936.
9. Windecker S, Kolh P, Alfonso et al. 2014 ESC/EACTS Guidelines 
on myocardial revascularization: The Task Force on Myocar-
dial Revascularization of the European Society of Cardiology 
(ESC) and the European Association for Cardio-Thoracic Surgery 
(EACTS)Developed with the special contribution of the Euro-
pean Association of Percutaneous Cardiovascular Interventions 
(EAPCI). Eur Heart J, 2014; 35: 2541–2619.
Table 4. Univariate and multivariate regression analysis for prediction of right ventricular dysfunction.
Variable Univariate Multivariate
Unadjusted  
odds ratio
95%  
confidence 
interval
P Adjusted 
odds ratio
95%  
confidence 
interval
P
Neutrophil/lymphocyte ratio 1.490 1.260–1.820 < 0.001 1.550 1.285–1.750 < 0.001
Glomerular filtration rate 0.975 0.912–1.025 0.312
Time from symptoms onset to PCI 1.375 1.083–1.820 0.007 1.320 1.085–1.810 0.008
Door to balloon time 0.950 0.895–1.035 0.130
Glucose on admission 1.005 0.995–1.013 0.212
Multivessel disease 0.445 0.223–0.875 0.020 0.440 0.235–0.824 0.03
Coronary lesion location 1.850 1.050–3.140 0.027 1.800 1.150–3.250 0.02
TIMI flow before PCI 1.205 0.970–1.680 0.092
TIMI flow after PCI 0.951 0.651–1.389 0.800
ST-elevation in lead V4R 3.800 1.55–13.5 < 0.001 2.700 1.825–9.255 < 0.001
LVEF in admission 0.795 0.709–1.027 0.225
PCI — percutaneous coronary intervention; TIMI — thrombolysis in myocardial infarction; LVEF — left ventricular ejection fraction
www.cardiologyjournal.org 105
Barıs Yaylak et al., Neutrophil/lymphocyte ratio and RV dysfunction
10. Lang RM, Badano LP, Mor-Avi V et al. Recommendations for 
cardiac chamber quantification by echocardiography in adults: 
An update from the American Society of Echocardiography and 
the European Association of Cardiovascular Imaging. J Am Soc 
Echocardiogr, 2015; 28: 1–39 e14.
11. Mann DL, Young JB. Basic mechanisms in congestive heart fail-
ure. Recognizing the role of proinflammatory cytokines. Chest, 
1994; 105: 897–904.
12. Torre-Amione G, Kapadia S, Benedict C, Oral H, Young JB, 
Mann DL. Proinflammatory cytokine levels in patients with 
depressed left ventricular ejection fraction: A report from the 
Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll 
Cardiol, 1996; 27: 1201–1206.
13. Reichlin T, Socrates T, Egli P et al. Use of myeloperoxidase for 
risk stratification in acute heart failure. Clin Chem, 2010; 56: 
944–951.
14. Baldus S, Heeschen C, Meinertz T et al. Myeloperoxidase serum 
levels predict risk in patients with acute coronary syndromes. 
Circulation, 2003; 108: 1440–1445.
15. Mehta J, Dinerman J, Mehta P et al. Neutrophil function in is-
chemic heart disease. Circulation, 1989; 79: 549–556.
16. Tousoulis D, Antoniades C, Koumallos N, Stefanadis C. Pro-in-
flammatory cytokines in acute coronary syndromes: From bench 
to bedside. Cytokine Growth Factor Rev, 2006; 17: 225–233.
17. Madjid M, Awan I, Willerson JT, Casscells SW. Leukocyte count 
and coronary heart disease: Implications for risk assessment. 
J Am Coll Cardiol, 2004; 44: 1945–1956.
18. Arruda-Olson AM, Reeder GS, Bell MR, Weston SA, Roger VL. 
Neutrophilia predicts death and heart failure after myocardial 
infarction: A community-based study. Circ Cardiovasc, Qual Out-
comes, 2009; 2: 656–662.
19. Kyne L, Hausdorff JM, Knight E, Dukas L, Azhar G, Wei JY. 
Neutrophilia and congestive heart failure after acute myocardial 
infarction. Am Heart J, 2000; 139: 94–100.
20. Onsrud M, Thorsby E. Influence of in vivo hydrocortisone 
on some human blood lymphocyte subpopulations. I. Effect on 
natural killer cell activity. Scand J Immunol, 1981; 13: 573– 
–579.
21. Hotchkiss RS, Karl IE. The pathophysiology and treatment of 
sepsis. N Engl J Med, 2003; 348: 138–150.
22. Widmer A, Linka AZ, Attenhofer Jost CH et al. Mechanical complica-
tions after myocardial infarction reliably predicted using C-reactive 
protein levels and lymphocytopenia. Cardiology, 2003; 99: 25–31.
23. Dragu R, Khoury S, Zuckerman R et al. Predictive value of white 
blood cell subtypes for long-term outcome following myocardial 
infarction. Atherosclerosis, 2008; 196: 405–412.
24. Horne BD, Anderson JL, John JM et al. Which white blood cell 
subtypes predict increased cardiovascular risk? J Am Coll Car-
diol, 2005; 45: 1638–1643.
25. Kalay N, Dogdu O, Koc F et al. Hematologic parameters and 
angiographic progression of coronary atherosclerosis. Angiology, 
2012; 63: 213–217.
26. Papa A, Emdin M, Passino C, Michelassi C, Battaglia D, Cocci F. 
Predictive value of elevated neutrophil-lymphocyte ratio on car-
diac mortality in patients with stable coronary artery disease. 
Clin Chim Acta, 2008; 395: 27–31.
27. Duffy BK, Gurm HS, Rajagopal V, Gupta R, Ellis SG, Bhatt DL. 
Usefulness of an elevated neutrophil to lymphocyte ratio in 
predicting long-term mortality after percutaneous coronary in-
tervention. Am J Cardiol, 2006; 97: 993–996.
28. Kaya MG, Akpek M, Lam YY et al. Prognostic value of neutro-
phil/lymphocyte ratio in patients with ST-elevated myocardial 
infarction undergoing primary coronary intervention: A prospec-
tive, multicenter study. Int J Cardiol, 2013; 168: 1154–1159.
29. Arbel Y, Shacham Y, Ziv-Baran T et al. Higher neutrophil/lympho-
cyte ratio is related to lower ejection fraction and higher long-
term all-cause mortality in ST-elevation myocardial infarction 
patients. Can J Cardiol, 2014; 30: 1177–1182.
30. Widimsky P, Budesinsky T, Vorac D et al. Long distance trans-
port for primary angioplasty vs immediate thrombolysis in acute 
myocardial infarction. Final results of the randomized national 
multicentre trial: PRAGUE-2. Eur Heart J, 2003; 24: 94–104.
106 www.cardiologyjournal.org
Cardiology Journal 2016, Vol. 23, No. 1
